Before You Read On
In a country where 87.7% of adults face Vitamin D insufficiency, how do leading institutionslike Greece's KAT Hospital ensure accurate assessment for their 16,000 annual surgeries?While Vitamin D is essential for bone healing, the path to accurate results is often blockedby the limitations of traditional immunoassays. In this episode, we dive into the future ofclinical testing, exploring how multiplex mass spectrometry and other innovative methodsare redefining diagnostic standards.
Key Highlights
- Special populations need special testing methods: High Vitamin D Binding Protein (VDBP) levels in maternal testing demand advanced and innovative diagnostic solutions to ensure precision.
- Metabolic ratios provide deeper insights: Measuring 24,25-dihydroxy vitamin D ratios reveals body's vitamin D efficiency beyond single markers.
- Future is multiplex testing: Advanced mass spectrometry can simultaneously detect multiple vitamin D forms, epimers, and metabolites.
Key Takeaways
Konstantinos Makris emphasizes that 25-hydroxy vitamin D is the primary test everyone should get because it shows how much vitamin D your body has available to make the active form. For special populations like pregnant women in the third trimester, regular immunoassays can underestimate vitamin D levels due to the inability to break down the association between vitamin D and highly elevated vitamin D binding protein. LC-MS/MS methods overcome this limitation by using stronger chemicals, making them the preferred choice for these cases.
On standardization, Makris notes that 25-hydroxy vitamin D measurement is well-standardized with reference methods, primary reference materials, and accuracy-based external quality assessment schemes like NEQAS. However, immunoassays may still show interference from vitamin D epimers. In contrast, 1,25-dihydroxy vitamin D and 24,25-dihydroxy vitamin D assays are not well-standardized, with 24,25-dihydroxy vitamin D only measurable via LC-MS/MS methods. He envisions future solutions in multiplex mass spectrometry methods.
Looking ahead, Makris sees three key trends for labs: more genetic testing, more molecular diagnostics, and a shift toward mass spectrometry for more accurate results. He also praises Mindray's fully automated systems that combine different testing functions, making lab work more efficient and controlled.
